Biotherapies, Inc.

Commercializing Mammastatin Serum Assay technology used to screen breast cancer risk
(1996)
Location:
Long Beach, CA
UM Inventor(s):
Paul R. Ervin
Acquisitions:
Genesis Bioventures [AMEX:GBI] in 2001, now Abviva [OTC;ABVV]
Commercializing Mammastatin Serum Assay technology used to screen breast cancer risk
(1996)
Location:
Long Beach, CA
UM Inventor(s):
Paul R. Ervin
Acquisitions:
Genesis Bioventures [AMEX:GBI] in 2001, now Abviva [OTC;ABVV]